ROSE REMEDY
DEAD

Serial Number

98406208

Owner

IRON REMEDY MD LLC

Attorney

Kia Kamran, Esq.

Filing Date

Feb 14, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ROSE REMEDY Trademark

Serial Number: 98406208

ROSE REMEDY is a trademark filed by IRON REMEDY MD LLC on February 14, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

IRON REMEDY MD LLC (2 trademarks)

1900 Avenue of the Stars, 25th Floor
Los Angeles, CA 90067

Entity Type: 16

Trademark Details

Filing Date

February 14, 2024

Registration Date

Not Registered

Goods & Services

Hormones; Vitamins; Analgesic preparations; Antifungal preparations; Dietary and nutritional supplements; Dietary and nutritional supplements for boosting energy; Dietary and nutritional supplements for promoting sleep; Dietary and nutritional supplements for replacing protein; Dietary and nutritional supplements for stimulating brain function; Dietary and nutritional supplements for promoting relaxation; Dietary and nutritional supplements for weight loss and weight management; Dietary and nutritional supplements for smoking cessation; Dietary and nutritional supplements for general health and wellbeing, for promoting weight loss, for promoting faster muscle recovery after exercise, and for building body mass and muscle mass and muscle mass; Fertility enhancement preparations; Gels for use as personal lubricant; Hormone replacement therapy preparations; Medical diagnostic test media in the form of blood or saliva markers using medical diagnostic reagents and assays for measuring and detecting of STDs, diabetes, hyperhidrosis, cancer, benign prostatic hyperplasia; Medical preparations for the treatment of andropause, erectile dysfunction and hormonal disorders; Medicated skin care preparations; Medicated skin preparation for use in treating acne; Mixed hormone preparations; Natural sleep aid preparations; Nutraceuticals for use as a dietary supplement; Pain relief medication; Personal lubricants; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of premature ejaculation; Pharmaceutical preparations for the treatment of anxiety; Pharmaceutical preparations for the treatment of psoriasis and eczema; Pharmaceutical preparations for the treatment of acid reflux; Pharmaceutical preparations for the treatment of sleep disorders; Pharmaceutical preparations for the treatment of allergies; Pharmaceutical preparations for the treatment of depression; Pharmaceutical preparations for the treatment of cardiovascular disorders; Pharmaceutical preparations for the treatment of Cholesterol reduction; Pharmaceutical preparations for the treatment of hair loss; Pharmaceutical preparations for the treatment of erectile dysfunction; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix containing collagen, protein, testosterone; Powdered nutritional supplement drink mix and concentrate; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Silicone-based personal lubricants; Topical preparations, namely, sprays, gels, creams for enhancing sexual arousal; Transdermal patches featuring vitamins for increasing energy; Water-based personal lubricants

Beauty consultation services; Consultation services in the field of palliative care; Consulting services in the field of health; Consulting services in the field of healthcare; Consulting services in the field of hormone replacement therapy; Consulting services in the field of mental fitness; Consulting services in the field of mental health and wellness; Consulting services in the field of women's health; Consulting services in the fields of diagnostic medical testing and nutrition; Consulting services in the fields of health and nutrition; Consulting services in the field of the diagnosis and treatment of andropause, erectile dysfunction and hormonal disorders; Food nutrition consultation; Health care services, namely, providing a database in the field of andropause, erectile dysfunction and hormonal disorders information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, wellness programs; Health care services, namely, hormone therapy; Human fertility treatment services; Interactive medical monitoring and alert service for reminding clients of medicinal dosage, allergic sensitivity, and prescription refills for medical treatment purposes; Medical analysis services relating to the treatment of patients; Medical and pharmaceutical consultation; Medical treatment of andropause, erectile dysfunction and hormonal disorders; Online cosmetic skincare consultation services; Preparation and dispensing of medications; Providing information about health, wellness and nutrition via a website; Providing information in the field of the diagnosis and treatment of reproductive health via a website; Providing information in the fields of diet and weight loss via a website; Providing medical information in the field of telehealth medicine health care; Providing medical information in the field of palliative care; Providing medical information in the field of diet, nutrition, weight management, weight loss and the maintenance of weight loss; Providing medical information in the field of men's sexual health; Providing medical information via a website; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Telemedicine services; Weight management services, namely, providing weight loss and/or weight maintenance programs; Weight reduction diet planning and supervision

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 6, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 6, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 15, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2024 NWOS
NEW APPLICATION ENTERED
Feb 15, 2024 NWAP